Skip to content
2000
image of Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for Progress

Abstract

Introduction

Endometriosis, a prevalent women's health condition, is associated with persistent pelvic pain and infertility. Despite ongoing research, its precise disease mechanism remains elusive, impeding the discovery of a definitive cure. However, the progression of this disease is driven by three central factors, namely estrogen, progesterone, and inflammatory processes. The current work summarizes an evaluation of hormonal drug therapy in endometriosis, highlighting pathogenesis, clinical studies, and the anticipated role of AI in improving diagnostic accuracy and therapeutic results.

Methods

Current information related to endometriosis and the application of AI in its diagnosis and treatment were evaluated through an in-depth literature search in the PubMed database and Google Scholar search engine.

Results

The current treatment modalities for this disease encompass drug therapy and surgery. In line with key contributing factors, the first-line pharmaceutical treatment revolves around progestin therapy, which involves administration either alone or in combination with a small amount of estrogen. Each medication is linked to certain drawbacks, encompassing bone loss associated with progesterone-only therapy, considerable cost implications, and heightened risks of bleeding, spotting, and drug intolerance when utilizing combined progesterone-estrogen therapy.

Conclusion

Many clinical studies on endometriosis are currently investigating the overall impact of the therapeutic approach involving progesterone-estrogen therapy with respect to the treatment of pelvic pain, health-related quality of life, cost-effectiveness, and tolerability. The rise of artificial intelligence and its advanced data processing capabilities present a promising opportunity to revolutionize endometriosis diagnosis and treatment by offering novel approaches.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128354055250312014359
2025-04-08
2025-11-03

  • From This Site

    /content/journals/cpd/10.2174/0113816128354055250312014359
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Tang W. Zhu X. Bian L. Zhang B. Research progress of dydrogesterone in the treatment of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2024 296 120 125 10.1016/j.ejogrb.2024.02.034 38430648
    [Google Scholar]
  2. Shi J. Tan X. Feng G. Zhuo Y. Jiang Z. Banda S. Wang L. Zheng W. Chen L. Yu D. Guo C. Research advances in drug therapy of endometriosis. Front. Pharmacol. 2023 14 1199010 10.3389/fphar.2023.1199010 37416064
    [Google Scholar]
  3. Koninckx P.R. Fernandes R. Ussia A. Schindler L. Wattiez A. Al-Suwaidi S. Amro B. Al-Maamari B. Hakim Z. Tahlak M. Pathogenesis based diagnosis and treatment of endometriosis. Front. Endocrinol. 2021 12 745548 10.3389/fendo.2021.745548 34899597
    [Google Scholar]
  4. Topçu EG Akgün N Karacan T et al. Medical treatment in endometriosis. Available from: https://www.endometriozisdernegi.org/wp-content/uploads/2021/03/endotaniing.docx-7- mart-2021.pdf
    [Google Scholar]
  5. Bedaiwy M.A. Alfaraj S. Yong P. Casper R. New developments in the medical treatment of endometriosis. Fertil. Steril. 2017 107 3 555 565 10.1016/j.fertnstert.2016.12.025 28139238
    [Google Scholar]
  6. Giudice L.C. Kao L.C. Endometriosis. Lancet 2004 364 9447 1789 1799 10.1016/S0140‑6736(04)17403‑5 15541453
    [Google Scholar]
  7. Meuleman C. Vandenabeele B. Fieuws S. Spiessens C. Timmerman D. D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil. Steril. 2009 92 1 68 74 10.1016/j.fertnstert.2008.04.056 18684448
    [Google Scholar]
  8. Guo S.W. Wang Y. The prevalence of endometriosis in women with chronic pelvic pain. Gynecol. Obstet. Invest. 2006 62 3 121 130 10.1159/000093019 16675908
    [Google Scholar]
  9. Maddern J. Grundy L. Castro J. Brierley S.M. Pain in endometriosis. Front. Cell. Neurosci. 2020 14 590823 10.3389/fncel.2020.590823 33132854
    [Google Scholar]
  10. Surrey E. Soliman A.M. Trenz H. Blauer-Peterson C. Sluis A. Impact of endometriosis diagnostic delays on healthcare resource utilization and costs. Adv. Ther. 2020 37 3 1087 1099 10.1007/s12325‑019‑01215‑x 31960340
    [Google Scholar]
  11. Dungate B. Tucker D.R. Goodwin E. Yong P.J. Assessing the utility of artificial intelligence in endometriosis: Promises and pitfalls. Womens Health 2024 20 17455057241248121 10.1177/17455057241248121 38686828
    [Google Scholar]
  12. Allaire C. Bedaiwy M.A. Yong P.J. Diagnosis and management of endometriosis. CMAJ 2023 195 10 E363 E371 10.1503/cmaj.220637 36918177
    [Google Scholar]
  13. Kleczyk EJ Peri A Yadav T Komera R Peri M Guduru V Predicting endometriosis onset using machine learning algorithms. 2020 10.21203/rs.3.rs‑135736/v1
    [Google Scholar]
  14. Hickey M. Ballard K. Farquhar C. Endometriosis. BMJ 2014 348 g1752 10.1136/bmj.g1752 24647161
    [Google Scholar]
  15. Bulletti C. Coccia M.E. Battistoni S. Borini A. Endometriosis and infertility. J. Assist. Reprod. Genet. 2010 27 8 441 447 10.1007/s10815‑010‑9436‑1 20574791
    [Google Scholar]
  16. Collins J.A. Burrows E.A. Willan A.R. The prognosis for live birth among untreated infertile couples. Fertil. Steril. 1995 64 1 22 28 10.1016/S0015‑0282(16)57650‑X 7789569
    [Google Scholar]
  17. Lalani S. Choudhry A.J. Firth B. Bacal V. Walker M. Wen S.W. Singh S. Amath A. Hodge M. Chen I. Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis. Hum. Reprod. 2018 33 10 1854 1865 10.1093/humrep/dey269 30239732
    [Google Scholar]
  18. Maggiore ULR Ferrero S. Mangili G. Bergamini A. Inversetti A. Giorgione V. Viganò P. Candiani M. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum. Reprod. Update 2016 22 1 70 103 10.1093/humupd/dmv045 26450609
    [Google Scholar]
  19. Breintoft K. Pinnerup R. Henriksen T.B. Rytter D. Uldbjerg N. Forman A. Arendt L.H. Endometriosis and risk of adverse pregnancy outcome: A systematic review and meta-analysis. J. Clin. Med. 2021 10 4 667 10.3390/jcm10040667 33572322
    [Google Scholar]
  20. Farland L.V. Prescott J. Sasamoto N. Tobias D.K. Gaskins A.J. Stuart J.J. Carusi D.A. Chavarro J.E. Horne A.W. Rich-Edwards J.W. Missmer S.A. Endometriosis and risk of adverse pregnancy outcomes. Obstet. Gynecol. 2019 134 3 527 536 10.1097/AOG.0000000000003410 31403584
    [Google Scholar]
  21. Bulletti F.M. Berrettini M. Sciorio R. Bulletti C. Artificial intelligence algorithms for optimizing assisted reproductive technology programs: A systematic review. Glob. Transl. Med. 2023 2 2 0308 10.36922/gtm.0308
    [Google Scholar]
  22. Kalaitzopoulos D.R. Samartzis N. Kolovos G.N. Mareti E. Samartzis E.P. Eberhard M. Dinas K. Daniilidis A. Treatment of endometriosis: A review with comparison of 8 guidelines. BMC Womens Health 2021 21 1 397 10.1186/s12905‑021‑01545‑5 34844587
    [Google Scholar]
  23. Valle R.F. Sciarra J.J. Endometriosis: Treatment strategies. Ann. N. Y. Acad. Sci. 2003 997 1 229 239 10.1196/annals.1290.026 14644830
    [Google Scholar]
  24. Kodaman P.H. Current strategies for endometriosis management. Obstet. Gynecol. Clin. 2015 42 1 87 101 25681842
    [Google Scholar]
  25. Barbara G. Buggio L. Facchin F. Vercellini P. Medical treatment for endometriosis: Tolerability, quality of life and adherence. Front. Glob. Womens Health 2021 2 729601 10.3389/fgwh.2021.729601 34816243
    [Google Scholar]
  26. Vannuccini S. Clemenza S. Rossi M. Petraglia F. Hormonal treatments for endometriosis: The endocrine background. Rev. Endocr. Metab. Disord. 2022 23 3 333 355 10.1007/s11154‑021‑09666‑w 34405378
    [Google Scholar]
  27. Rojek K. Juda A. Kamińska M. Strzoda A. Strzoda A. Sowiński W. Progestins and combined oral contraceptives in the hormonal treatment of endometriosis – A review. Eur J Clin Exp Med 2023 21 2 397 404 10.15584/ejcem.2023.2.21
    [Google Scholar]
  28. Lamceva J. Uljanovs R. Strumfa I. The main theories on the pathogenesis of endometriosis. Int. J. Mol. Sci. 2023 24 5 4254 10.3390/ijms24054254 36901685
    [Google Scholar]
  29. Liu Z. Yan Y. Liu Z. Wang Y. Inflammation and endometriosis. Front. Biosci. 2016 21 5 941 948 10.2741/4431 27100482
    [Google Scholar]
  30. Zhang M. Xu T. Tong D. Li S. Yu X. Liu B. Jiang L. Liu K. Research advances in endometriosis-related signaling pathways: A review. Biomed. Pharmacother. 2023 164 114909 10.1016/j.biopha.2023.114909 37210898
    [Google Scholar]
  31. Giudice L.C. Oskotsky T.T. Falako S. Opoku-Anane J. Sirota M. Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations. FASEB J. 2023 37 9 e23130 10.1096/fj.202300907 37641572
    [Google Scholar]
  32. Donnez J. Dolmans M.M. Endometriosis and medical therapy: From progestogens to progesterone resistance to GnRH antagonists: A review. J. Clin. Med. 2021 10 5 1085 10.3390/jcm10051085 33807739
    [Google Scholar]
  33. Yilmaz B.D. Bulun S.E. Endometriosis and nuclear receptors. Hum. Reprod. Update 2019 25 4 473 485 10.1093/humupd/dmz005 30809650
    [Google Scholar]
  34. Kapoor R. Stratopoulou C.A. Dolmans M.M. Pathogenesis of endometriosis: New insights into prospective therapies. Int. J. Mol. Sci. 2021 22 21 11700 10.3390/ijms222111700 34769130
    [Google Scholar]
  35. Marquardt R.M. Kim T.H. Shin J.H. Jeong J.W. Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis? Int. J. Mol. Sci. 2019 20 15 3822 10.3390/ijms20153822 31387263
    [Google Scholar]
  36. Koukoura O. Sifakis S. Spandidos D.A. DNA methylation in endometriosis (Review). Mol. Med. Rep. 2016 13 4 2939 2948 10.3892/mmr.2016.4925 26934855
    [Google Scholar]
  37. Kim J.J. Kurita T. Bulun S.E. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr. Rev. 2013 34 1 130 162 10.1210/er.2012‑1043 23303565
    [Google Scholar]
  38. Rižner T.L. Estrogen metabolism and action in endometriosis. Mol. Cell. Endocrinol. 2009 307 1-2 8 18 10.1016/j.mce.2009.03.022 19524121
    [Google Scholar]
  39. Becker C.M. Bokor A. Heikinheimo O. Horne A. Jansen F. Kiesel L. King K. Kvaskoff M. Nap A. Petersen K. Saridogan E. Tomassetti C. van Hanegem N. Vulliemoz N. Vermeulen N. Altmäe S. Ata B. Ball E. Barra F. Bastu E. Bianco-Anil A. Knudsen U.B. Brubel R. Cambitzi J. Cantineau A. Cheong Y. Daniilidis A. De Bie B. Exacoustos C. Ferrero S. Gelbaya T. Goetz-Collinet J. Hudelist G. Hussain M. Indrielle-Kelly T. Khazali S. Kumar S.L. Leone Roberti Maggiore U. Maas J.W.M. McLaughlin H. Metello J. Mijatovic V. Miremadi Y. Muteshi C. Nisolle M. Oral E. Pados G. Parades D. Pluchino N. Supramaniam P.R. Schick M. Seeber B. Seracchioli R. Laganà A.S. Stavroulis A. Tebache L. Uncu G. Van den Broeck U. van Peperstraten A. Vereczkey A. Wolthuis A. Bahat P.Y. Yazbeck C. ESHRE Endometriosis Guideline Group ESHRE guideline: Endometriosis. Hum. Reprod. Open 2022 2022 2 hoac009 10.1093/hropen/hoac009 35350465
    [Google Scholar]
  40. Lee J. Park H.J. Yi K.W. Dienogest in endometriosis treatment: A narrative literature review. Clin. Exp. Reprod. Med. 2023 50 4 223 229 10.5653/cerm.2023.06128 37995750
    [Google Scholar]
  41. Elbasueny B. Geerts M. Yang E.C. Allaire C. Yong P.J. Bedaiwy M.A. Medical treatments of endometriosis: A review. Reprod. Dev. Med. 2023 7 3 166 179 10.1097/RD9.0000000000000053
    [Google Scholar]
  42. Vercellini P. Ottolini F. Frattaruolo M.P. Buggio L. Roberto A. Somigliana E. Shifting from oral contraceptives to norethisterone acetate, or vice versa, because of drug intolerance: Does the change benefit women with endometriosis? Gynecol. Obstet. Invest. 2018 83 3 275 284 10.1159/000486335 29486468
    [Google Scholar]
  43. Obstetricians ACo Practice bulletin no. 114: Management of endometriosis. Obstet. Gynecol. 2010 116 1 223 236 10.1097/AOG.0b013e3181e8b073 20567196
    [Google Scholar]
  44. Leyland N. Casper R. Laberge P. Singh S.S. Allen L. Arendas K. SOGC Endometriosis: Diagnosis and management. J. Endometr. 2010 32 7 Suppl. 2 S1 32 21545757
    [Google Scholar]
  45. Dunselman G.A.J. Vermeulen N. Becker C. Calhaz-Jorge C. D’Hooghe T. De Bie B. Heikinheimo O. Horne A.W. Kiesel L. Nap A. Prentice A. Saridogan E. Soriano D. Nelen W. European Society of Human Reproduction and Embryology ESHRE guideline: Management of women with endometriosis. Hum. Reprod. 2014 29 3 400 412 10.1093/humrep/det457 24435778
    [Google Scholar]
  46. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: A committee opinion. Fertil. Steril. 2014 101 4 927 935 10.1016/j.fertnstert.2014.02.012 24630080
    [Google Scholar]
  47. García-Sáenz M. Ibarra-Salce R. Pozos-Varela F.J. Mena-Ureta T.S. Flores-Villagómez S. Santana-Mata M. De Los Santos-Aguilar R.G. Uribe-Cortés D. Ferreira-Hermosillo A. Understanding progestins: From basics to clinical applicability. J. Clin. Med. 2023 12 10 3388 10.3390/jcm12103388 37240495
    [Google Scholar]
  48. Fedotcheva T. Clinical use of progestins and their mechanisms of action: Present and future. Modern Technol. Med. 2021 13 1 93 106 10.17691/stm2021.13.1.11
    [Google Scholar]
  49. McCormack P.L. Dienogest. Drugs 2010 70 16 2073 2088 10.2165/11206320‑000000000‑00000 20964453
    [Google Scholar]
  50. Kim Y.S. Kim Y.J. Kim M.J. Lee S.J. Kwon H. Lee J.H. Novel medicine for endometriosis and its therapeutic effect in a mouse model. Biomedicines 2020 8 12 619 10.3390/biomedicines8120619 33339236
    [Google Scholar]
  51. Tarjanne S. Ng C.H.M. Manconi F. Arola J. Mentula M. Maneck B. Fraser I.S. Heikinheimo O. Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis. Acta Obstet. Gynecol. Scand. 2015 94 7 693 700 10.1111/aogs.12652 25865020
    [Google Scholar]
  52. Shah M. Dave B. Bhagat S. Rao H. Khadela A. Parikh N. A comprehensive review comparing conventional versus traditional remedies in the treatment of endometriosis with futuristic insights. Future J. Pharm. Sci. 2024 10 1 35 10.1186/s43094‑024‑00609‑1
    [Google Scholar]
  53. Mikuš M. Goldštajn MS Laganà A.S. Vukorepa F. Ćorić M. Clinical efficacy, pharmacokinetics, and safety of the available medical options in the treatment of endometriosis-related pelvic pain: A scoping review. Pharmaceuticals (Basel) 2023 16 9 1315 10.3390/ph16091315 37765123
    [Google Scholar]
  54. Tokushige N. Markham R. Russell P. Fraser I.S. Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis. Fertil. Steril. 2009 92 4 1234 1239 10.1016/j.fertnstert.2008.07.1774 18976764
    [Google Scholar]
  55. Yamamoto N. Wada-Hiraike O. Hirano M. Hirata T. Harada M. Hirota Y. Koga K. Fujii T. Osuga Y. Ovarian reserve may influence the outcome of bone mineral density in patients with long-term use of dienogest. SAGE Open Med. 2021 9 20503121211005992 10.1177/20503121211005992 35154758
    [Google Scholar]
  56. Gallo MF Nanda K Grimes DA Lopez LM Schulz KF 20 µg versus > 20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst. Rev. 2013 8 CD003989 10.3390/ph16091315 37765123
    [Google Scholar]
  57. Vercellini P Buggio L Berlanda N Barbara G Somigliana E Bosari S Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril 2016 106 7 1552 1571 10.1016/j.fertnstert.2016.10.022
    [Google Scholar]
  58. Reis F.M. Petraglia F. Taylor R.N. Endometriosis: Hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum. Reprod. Update 2013 19 4 406 418 10.1093/humupd/dmt010 23539633
    [Google Scholar]
  59. Meresman G.F. Augé L. Barañao R.I. Lombardi E. Tesone M. Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil. Steril. 2002 77 6 1141 1147 10.1016/S0015‑0282(02)03099‑6 12057719
    [Google Scholar]
  60. Chen L.H. Lo W.C. Huang H.Y. Wu H.M. A lifelong impact on endometriosis: Pathophysiology and pharmacological treatment. Int. J. Mol. Sci. 2023 24 8 7503 10.3390/ijms24087503 37108664
    [Google Scholar]
  61. Akahane T. Sekizawa A. Purwosunu Y. Nagatsuka M. Okai T. The role of p53 mutation in the carcinomas arising from endometriosis. Int. J. Gynecol. Pathol. 2007 26 3 345 351 10.1097/pgp.0b013e31802b41a8 17581423
    [Google Scholar]
  62. Caruso S. Cianci A. Iraci M. Fava V. Di Pasqua S. Cianci S. Does nomegestrol acetate plus 17β-estradiol oral contraceptive improve endometriosis-associated chronic pelvic pain in women? J. Womens Health 2020 29 9 1184 1191 10.1089/jwh.2020.8291 32678691
    [Google Scholar]
  63. Caruso S. Cianci A. Sareri MI Panella M. Caruso G. Cianci S. Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis-associated chronic pelvic pain. BMC Womens Health 2022 22 1 146 10.1186/s12905‑022‑01737‑7 35538479
    [Google Scholar]
  64. Surrey E.S. GnRH agonists in the treatment of symptomatic endometriosis: A review. F S Rep. 2023 4 2 Suppl. 40 45 10.1016/j.xfre.2022.11.009 37223763
    [Google Scholar]
  65. de Ziegler D Borghese B Chapron C Gonadotropin-releasing hormone agonists for endometriosis. N. Engl. J. Med. 2008 359 26 2844
    [Google Scholar]
  66. Donnez J. Chantraine F. Nisolle M. The efficacy of medical and surgical treatment of endometriosis-associated infertility: Arguments in favour of a medico-surgical aproach. Hum. Reprod. Update 2002 8 1 89 94 10.1093/humupd/8.1.89 11866245
    [Google Scholar]
  67. Donnez J. Nisolle M. Clerckx F. Casanas-Roux F. Saussoy P. Gillerot S. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment. BJOG 1994 101 s10 Suppl. 10 2 9 10.1111/j.1471‑0528.1994.tb13677.x 8199099
    [Google Scholar]
  68. Donnez J. Taylor H.S. Taylor R.N. Akin M.D. Tatarchuk T.F. Wilk K. Gotteland J.P. Lecomte V. Bestel E. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: A randomized clinical trial. Fertil. Steril. 2020 114 1 44 55 10.1016/j.fertnstert.2020.02.114 32505383
    [Google Scholar]
  69. Cooper KG Bhattacharya S Daniels JP Horne AW Clark TJ Saridogan E Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial. BMJ 2024 385 e079006 10.1136/bmj‑2023‑079006
    [Google Scholar]
  70. Steiner J. Walter M. Gos T. Guillemin G.J. Bernstein H.G. Sarnyai Z. Mawrin C. Brisch R. Bielau H. zu Schwabedissen L. Bogerts B. Myint A.M. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation 2011 8 1 94 10.1186/1742‑2094‑8‑94 21831269
    [Google Scholar]
  71. Canday M. Salman S. Impact of dienogest alone or in combination with ethinylestradiol on the quality of life of women with endometriosis: A prospective cohort study. Gynecol. Obstet. Reprod. Med. 2023 29 3 196 205
    [Google Scholar]
  72. Yurtkal A. Oncul M. Comparison of dienogest or combinations with ethinylestradiol/estradiol valerate on the pain score of women with endometriosis: A prospective cohort study. Medicine 2024 103 27 e38585 10.1097/MD.0000000000038585 38968535
    [Google Scholar]
  73. Zhang Z. Wang X. Wang L. Li Z. Cost-effectiveness analysis of dienogest compared with combined oral contraceptives after surgery for endometriosis. J. Minim. Invasive Gynecol. 2023 30 4 312 318 10.1016/j.jmig.2022.12.017 36596391
    [Google Scholar]
  74. da Costa Pinheiro D.J.P. Pereira A.M.G. Antonini M. Salgado IMA Dias A.T. Lopes R.G.C. Tolerability of endometriosis medical treatment: A comparison between combined hormonal contraceptives and progestins. BMC Womens Health 2023 23 1 510 10.1186/s12905‑023‑02647‑y 37741998
    [Google Scholar]
  75. Shim J.Y. Garbo G. Grimstad F.W. Scatoni A. Barrera E.P. Boskey E.R. Use of the drospirenone-only contraceptive pill in adolescents with endometriosis. J. Pediatr. Adolesc. Gynecol. 2024 37 4 402 406 10.1016/j.jpag.2024.02.003 38395193
    [Google Scholar]
  76. Dababou S. Garzon S. Laganà A.S. Ferrero S. Evangelisti G. Noventa M. D’Alterio M.N. Palomba S. Uccella S. Franchi M. Barra F. Linzagolix: A new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opin. Investig. Drugs 2021 30 9 903 911 10.1080/13543784.2021.1957830 34278887
    [Google Scholar]
  77. Filip L. Duică F. Prădatu A. Crețoiu D. Suciu N. Crețoiu S.M. Predescu D.V. Varlas V.N. Voinea S.C. Endometriosis associated infertility: A critical review and analysis on etiopathogenesis and therapeutic approaches. Medicina 2020 56 9 460 10.3390/medicina56090460 32916976
    [Google Scholar]
  78. Macer M.L. Taylor H.S. Endometriosis and infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin 2012 39 4 535 549 23182559
    [Google Scholar]
  79. Guo Y. Lu N. Zhang Y. Su Y. Wang Y. Zhang Y. Sun Y. Comparative study on the pregnancy outcomes of in vitro fertilization–embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone. Contemp. Clin. Trials 2012 33 6 1206 1210 10.1016/j.cct.2012.07.009 22820320
    [Google Scholar]
  80. Cao X. Chang H. Xu J. Zheng Y. Xiang Y. Xiao B. Geng X. Ni L. Chu X. Tao S. He Y. Mao G. The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: A meta-analysis. Reprod. Biol. Endocrinol. 2020 18 1 16 10.1186/s12958‑020‑00571‑6 32113479
    [Google Scholar]
  81. Pašalić E. Tambuwala M.M. Hromić-Jahjefendić A. Endometriosis: Classification, pathophysiology, and treatment options. Pathol. Res. Pract. 2023 251 154847 10.1016/j.prp.2023.154847 37844487
    [Google Scholar]
  82. Hodgson RM Lee HL Wang R Mol BW Johnson N Interventions for endometriosis-related infertility: A systematic review and network meta-analysis. Fertil Steril 2020 113 2 374 382 10.1016/j.fertnstert.2019.09.031
    [Google Scholar]
  83. Alkatout I. Mettler L. Beteta C. Hedderich J. Jonat W. Schollmeyer T. Salmassi A. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J. Minim. Invasive Gynecol. 2013 20 4 473 481 10.1016/j.jmig.2013.01.019 23567095
    [Google Scholar]
  84. Stochino-Loi E. Millochau J.C. Angioni S. Touleimat S. Abo C. Chanavaz-Lacheray I. Hennetier C. Roman H. Relationship between patient age and disease features in a prospective cohort of 1560 women affected by endometriosis. J. Minim. Invasive Gynecol. 2020 27 5 1158 1166 10.1016/j.jmig.2019.09.004 31518709
    [Google Scholar]
  85. Capezzuoli T. Vannuccini S. Mautone D. Sorbi F. Chen H. Reis F.M. Ceccaroni M. Petraglia F. Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence. Reprod. Biomed. Online 2021 42 2 451 456 10.1016/j.rbmo.2020.09.018 33277193
    [Google Scholar]
  86. Lee D. Kim S.K. Lee J.R. Jee B.C. Management of endometriosis-related infertility: Considerations and treatment options. Clin. Exp. Reprod. Med. 2020 47 1 1 11 10.5653/cerm.2019.02971 32088944
    [Google Scholar]
  87. Tanbo T. Fedorcsak P. Endometriosis-associated infertility: Aspects of pathophysiological mechanisms and treatment options. Acta Obstet. Gynecol. Scand. 2017 96 6 659 667 10.1111/aogs.13082 27998009
    [Google Scholar]
  88. Cetera G.E. Tozzi A.E. Chiappa V. Castiglioni I. Merli C.E.M. Vercellini P. Artificial intelligence in the management of women with endometriosis and adenomyosis: Can machines ever be worse than humans? J. Clin. Med. 2024 13 10 2950 10.3390/jcm13102950 38792490
    [Google Scholar]
  89. Deo R.C. Machine learning in medicine. Circulation 2015 132 20 1920 1930 10.1161/CIRCULATIONAHA.115.001593 26572668
    [Google Scholar]
  90. Wang R. Pan W. Jin L. Li Y. Geng Y. Gao C. Chen G. Wang H. Ma D. Liao S. Artificial intelligence in reproductive medicine. Reproduction 2019 158 4 R139 R154 10.1530/REP‑18‑0523 30970326
    [Google Scholar]
  91. Visalaxi S. Punnoose D. Muthu T.S. An analogy of endometriosis recognition using machine learning techniques. 2021 Third International Conference on Intelligent Communication Technologies and Virtual Mobile Networks (ICICV) Tirunelveli, India, 2021, pp. 739-746. 10.1109/ICICV50876.2021.9388403
    [Google Scholar]
  92. Serrat JC Evaluation of the combination of magnetic resonance imaging and artificial intelligence in the diagnosis of endometriosis: A cross-sectional study. 2022 Available from: https://dugi-doc.udg.edu/handle/10256/21546
  93. Maicas G. Leonardi M. Avery J. Panuccio C. Carneiro G. Hull M.L. Condous G. Deep learning to diagnose pouch of Douglas obliteration with ultrasound sliding sign. Reprod. Fertil. 2021 2 4 236 243 10.1530/RAF‑21‑0031 35118401
    [Google Scholar]
  94. Sivajohan B. Elgendi M. Menon C. Allaire C. Yong P. Bedaiwy M.A. Clinical use of artificial intelligence in endometriosis: A scoping review. NPJ Digit. Med. 2022 5 1 109 10.1038/s41746‑022‑00638‑1 35927426
    [Google Scholar]
  95. Goldstein A. Cohen S. Self-report symptom-based endometriosis prediction using machine learning. Sci. Rep. 2023 13 1 5499 10.1038/s41598‑023‑32761‑8 37016132
    [Google Scholar]
  96. Ghazi N. Arjmand M. Akbari Z. Mellati AO Saheb-Kashaf H. Zamani Z. 1H NMR- based metabolomics approaches as non- invasive tools for diagnosis of endometriosis. Int. J. Reprod. Biomed. 2016 14 1 1 8 10.29252/ijrm.14.1.1 27141542
    [Google Scholar]
  97. Hosna A. Merry E. Gyalmo J. Alom Z. Aung Z. Azim M.A. Transfer learning: A friendly introduction. J. Big Data 2022 9 1 102 10.1186/s40537‑022‑00652‑w 36313477
    [Google Scholar]
  98. Vesale E. Roman H. Abo C. Benoit L. Tuech J.J. Darai E. Bendifallah S. Predictive approach in managing voiding dysfunction after surgery for deep endometriosis: A personalized nomogram. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2021 32 5 1205 1212 10.1007/s00192‑020‑04428‑9 32653970
    [Google Scholar]
  99. Dutta M. Joshi M. Srivastava S. Lodh I. Chakravarty B. Chaudhury K. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol. Biosyst. 2012 8 12 3281 3287 10.1039/c2mb25353d 23079773
    [Google Scholar]
  100. Bendifallah S. Suisse S. Puchar A. Delbos L. Poilblanc M. Descamps P. Golfier F. Jornea L. Bouteiller D. Touboul C. Dabi Y. Daraï E. Salivary MicroRNA signature for diagnosis of endometriosis. J. Clin. Med. 2022 11 3 612 10.3390/jcm11030612 35160066
    [Google Scholar]
  101. Avery J.C. Deslandes A. Freger S.M. Leonardi M. Lo G. Carneiro G. Condous G. Hull M.L. Hull L. Carneiro G. Avery J. O’Hara R. Condous G. Knox S. Leonardi M. Panuccio C. Sirop A. Abbott J. Gonzalez-Chica D. Wang H. Lo G. Chen T. Deslandes A. To M-S. Zhang Y. Yang N. Uzuner C. Holdsworth-Carson S. Nguyen T. Freger S. Abeygunasekara N. Richards M. Simpson A. Voyvodic F. Jenkins M. Imagendo Study Group Noninvasive diagnostic imaging for endometriosis part 1: A systematic review of recent developments in ultrasound, combination imaging, and artificial intelligence. Fertil. Steril. 2024 121 2 164 188 10.1016/j.fertnstert.2023.12.008 38101562
    [Google Scholar]
  102. Scutari M. Denis J-B. Bayesian networks: With examples in R, 3rd ed; Chapman and Hall/CRC 2021; pp. 274. 10.1201/9780429347436
  103. Pearl J. Probabilistic reasoning in intelligent systems: Networks of plausible inference. Morgan Kaufmann Publishers Inc., San Francisco, CA, USA 1988. Available from: https://dl.acm.org/doi/book/10.5555/ 534975.
  104. Kiser A.C. Schliep K.C. Hernandez E.J. Peterson C.M. Yandell M. Eilbeck K. An artificial intelligence approach for investigating multifactorial pain-related features of endometriosis. PLoS One 2024 19 2 e0297998 10.1371/journal.pone.0297998 38381710
    [Google Scholar]
  105. Jiang N. Xie H. Lin J. Wang Y. Yin Y. Diagnosis and nursing intervention of gynecological ovarian endometriosis with magnetic resonance imaging under artificial intelligence algorithm. Comput. Intell. Neurosci. 2022 2022 1 1 10 10.1155/2022/3123310 35726287
    [Google Scholar]
  106. Albizu A. Fang R. Indahlastari A. O’Shea A. Stolte S.E. See K.B. Boutzoukas E.M. Kraft J.N. Nissim N.R. Woods A.J. Machine learning and individual variability in electric field characteristics predict tDCS treatment response. Brain Stimul. 2020 13 6 1753 1764 10.1016/j.brs.2020.10.001 33049412
    [Google Scholar]
  107. Indrielle-Kelly T. Frühauf F. Fanta M. Burgetova A. Lavu D. Dundr P. Cibula D. Fischerova D. Diagnostic accuracy of ultrasound and MRI in the mapping of deep pelvic endometriosis using the international deep endometriosis analysis (IDEA) consensus. BioMed Res. Int. 2020 2020 1 3583989 10.1155/2020/3583989 32083128
    [Google Scholar]
  108. Zhang Y. Wang H. Butler D. To M-S. Avery J. Hull M.L. Carneiro G. Distilling missing modality knowledge from ultrasound for endometriosis diagnosis with magnetic resonance images. 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI) Cartagena, Colombia, 2023, pp. 1-5. 10.1109/ISBI53787.2023.10230667
    [Google Scholar]
  109. Avery J.C. Knox S. Deslandes A. Leonardi M. Lo G. Wang H. Zhang Y. Holdsworth-Carson S.J. Thi Nguyen T.T. Condous G.S. Carneiro G. Hull M.L. Hull L. Carneiro G. Avery J. O’Hara R. Condous G. Knox S. Leonardi M. Panuccio C. Sirop A. Abbott J. Gonzalez-Chica D. Wang H. Lo G. Chen T. Deslandes A. To M-S. Zhang Y. Yang N. Uzuner C. Holdsworth-Carson S. Nguyen T. Freger S. Abeygunasekara N. Richards M. Simpson A. Voyvodic F. Jenkins M. Imagendo Study Group Noninvasive diagnostic imaging for endometriosis part 2: A systematic review of recent developments in magnetic resonance imaging, nuclear medicine and computed tomography. Fertil. Steril. 2024 121 2 189 211 10.1016/j.fertnstert.2023.12.017 38110143
    [Google Scholar]
  110. Rajput D. Wang W.J. Chen C.C. Evaluation of a decided sample size in machine learning applications. BMC Bioinformatics 2023 24 1 48 10.1186/s12859‑023‑05156‑9 36788550
    [Google Scholar]
  111. Vabalas A. Gowen E. Poliakoff E. Casson A.J. Machine learning algorithm validation with a limited sample size. PLoS One 2019 14 11 e0224365 10.1371/journal.pone.0224365 31697686
    [Google Scholar]
  112. Kernbach JM Staartjes VE Foundations of machine learning-based clinical prediction modeling: Part II-generalization and overfitting. Acta Neurochir. Suppl. 2022 134 15 21 10.1007/978‑3‑030‑85292‑4_3
    [Google Scholar]
  113. Ying X. An overview of overfitting and its solutions. J. Phys.: Conf. Ser. 2019 1168 022022
    [Google Scholar]
  114. Kokol P. Kokol M. Zagoranski S. Machine learning on small size samples: A synthetic knowledge synthesis. Sci. Prog. 2022 105 1 00368504211029777 10.1177/00368504211029777 35220816
    [Google Scholar]
  115. Laufer M.R. Goitein L. Bush M. Cramer D.W. Emans S.J. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J. Pediatr. Adolesc. Gynecol. 1997 10 4 199 202 10.1016/S1083‑3188(97)70085‑8 9391902
    [Google Scholar]
  116. Reese K.A. Reddy S. Rock J.A. Endometriosis in an adolescent population: The Emory experience. J. Pediatr. Adolesc. Gynecol. 1996 9 3 125 128 10.1016/S1083‑3188(96)70021‑9 8795787
    [Google Scholar]
  117. Koninckx P.R. Meuleman C. Demeyere S. Lesaffre E. Cornillie F.J. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil. Steril. 1991 55 4 759 765 10.1016/S0015‑0282(16)54244‑7 2010001
    [Google Scholar]
  118. Laufer M.R. Sanfilippo J. Rose G. Adolescent endometriosis. J. Pediatr. Adolesc. Gynecol. 2003 16 3 Suppl. S3 11 10.1016/S1083‑3188(03)00066‑4 12742180
    [Google Scholar]
  119. Sarıdoğan E. Adolescent endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017 209 46 49 10.1016/j.ejogrb.2016.05.019 27342684
    [Google Scholar]
  120. Zannoni L. Forno S.D. Paradisi R. Seracchioli R. Endometriosis in adolescence: Practical rules for an earlier diagnosis. Pediatr. Ann. 2016 45 9 e332 e335 10.3928/19382359‑20160727‑03 27622918
    [Google Scholar]
  121. Marsh E.E. Laufer M.R. Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly. Fertil. Steril. 2005 83 3 758 760 10.1016/j.fertnstert.2004.08.025 15749511
    [Google Scholar]
  122. Saridoğan E. Endometriosis in teenagers. Womens Health 2015 11 5 705 709 10.2217/whe.15.58 26315257
    [Google Scholar]
  123. Chapron C. Lafay-Pillet M.C. Monceau E. Borghese B. Ngô C. Souza C. de Ziegler D. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil. Steril. 2011 95 3 877 881 10.1016/j.fertnstert.2010.10.027 21071024
    [Google Scholar]
  124. Hanassab S. Abbara A. Yeung A.C. Voliotis M. Tsaneva-Atanasova K. Kelsey T.W. Trew G.H. Nelson S.M. Heinis T. Dhillo W.S. The prospect of artificial intelligence to personalize assisted reproductive technology. NPJ Digit. Med. 2024 7 1 55 10.1038/s41746‑024‑01006‑x 38429464
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128354055250312014359
Loading
Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for Progress
Bentham Science Publishers ; https://doi.org/10.2174/0113816128354055250312014359
/content/journals/cpd/10.2174/0113816128354055250312014359
/content/journals/cpd/10.2174/0113816128354055250312014359
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: infertility ; progesterone ; pelvic pain ; estrogen ; inflammation ; Endometriosis ; artificial intelligence

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test